Aveanna holders sell 16.8M shares at $11.50
Aveanna Healthcare Holdings, Inc. (AVAH) reports that entities associated with reporting person Paul R. Vigano sold an aggregate of 16,750,002 shares of common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. (AVAH) reports that entities associated with reporting person Paul R. Vigano sold an aggregate of 16,750,002 shares of common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026. The sales were made indirectly through several investment and holding entities, and Vigano disclaims beneficial ownership except to the extent of his pecuniary interest.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 16,750,002 shares
Net Sell
7 txns
Insider
VIGANO PAUL R
Role
10% Owner
Sold
16,750,002 shs ($192.63M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value F10, F1 | 2,250,000 | $11.50 | $25.88M |
| Sale | Common Stock, $0.01 par value F5, F1 | 10,112,125 | $11.50 | $116.29M |
| Sale | Common Stock, $0.01 par value F6, F1 | 957,918 | $11.50 | $11.02M |
| Sale | Common Stock, $0.01 par value F7, F2 | 1,813,795 | $11.50 | $20.86M |
| Sale | Common Stock, $0.01 par value F8, F1 | 1,426,034 | $11.50 | $16.40M |
| Sale | Common Stock, $0.01 par value F9, F2, F3 | 190,130 | $11.50 | $2.19M |
| holding | Common Stock, $0.01 par value F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 par value — 0 shares (Indirect, By J.H. Whitney VII, L.P.);
Common Stock, $0.01 par value — 0 shares (Indirect, By JHW Iliad Holdings, LLC);
Common Stock, $0.01 par value — 0 shares (Indirect, By PSA Iliad Holdings LLC);
Common Stock, $0.01 par value — 0 shares (Indirect, By JHW Iliad Holdings II, LLC);
Common Stock, $0.01 par value — 12,315,892 shares (Indirect, By PSA Healthcare Investment Holding LLC);
Common Stock, $0.01 par value — 0 shares (Direct)
Footnotes (10)
- F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F4. Paul R. Vigano is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F5. On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
- F6. On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
- F7. On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.
- F8. On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.
- F9. On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
- F10. On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
Key Figures
Aggregate shares sold: 16,750,002 shares
Sale price per share: $11.50 per share
Shares sold by J.H. Whitney VII, L.P.: 10,112,125 shares
+5 more
8 metrics
Aggregate shares sold
16,750,002 shares
Total Aveanna common shares sold by affiliated entities on August 20–21, 2026
Sale price per share
$11.50 per share
Price for each reported sale of Aveanna common stock
Shares sold by J.H. Whitney VII, L.P.
10,112,125 shares
Sold on August 20, 2026 in an underwritten secondary offering
Shares sold by PSA Healthcare Investment Holding LLC (Aug 20)
957,918 shares
Sold on August 20, 2026 in an underwritten secondary offering
Additional shares sold by PSA Healthcare Investment Holding LLC (Aug 21)
2,250,000 shares
Sold on August 21, 2026 pursuant to option to purchase additional shares
Shares sold by PSA Iliad Holdings LLC
1,426,034 shares
Sold on August 20, 2026 in an underwritten secondary offering
Shares sold by JHW Iliad Holdings, LLC
1,813,795 shares
Sold on August 20, 2026 in an underwritten secondary offering
Shares sold by JHW Iliad Holdings II, LLC
190,130 shares
Sold on August 20, 2026 in an underwritten secondary offering
Key Terms
underwritten secondary offering, option to purchase additional Shares, disclaims beneficial ownership, pecuniary interest, +1 more
5 terms
underwritten secondary offering financial
"sold 10,112,125 Shares pursuant to an underwritten secondary offering"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
disclaims beneficial ownership financial
"disclaims beneficial ownership of such securities except to the extent of its pecuniary"
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of its pecuniary"
voting and dispositive power financial
"may be deemed to share voting and dispositive power with respect to the Shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 4 report for Aveanna Healthcare Holdings, Inc. (AVAH)?
It reported that entities associated with Paul R. Vigano sold an aggregate of 16,750,002 shares of Aveanna common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026, through several affiliated investment and holding entities.
Were the AVAH sales made directly by Paul R. Vigano?
No. The sales were made indirectly by various stockholder entities such as J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and others. Footnotes state that Paul R. Vigano may be deemed to share voting and dispositive power but disclaims beneficial ownership except for his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
